Sudeep Pharma to host investor meet at Nuvama forum on Sep 28

0 min read | Published on 23 Sept 2026, 03:19 PM |Updated on 23 Sept 2026, 03:19 PM

Reviewed by

Jubin VScanX News Team

Add as a preferred
source on Google

Key Highlights

Sudeep Pharma officials will attend the Nuvama Emerging India CEO Forum 2026 in Mumbai on September 28, 2026
The meeting starts at 10:00 am and includes one-on-one and group interactions
Discussions are restricted to publicly available information with no UPSI sharing
The company filed this intimation under Regulation 30(6) of SEBI Listing Regulations

*this image is generated using AI for illustrative purposes only.

Sudeep Pharma officials will attend the Nuvama Emerging India CEO Forum 2026 in Mumbai on September 28, 2026. The company confirmed that discussions will be limited to publicly available information.

Meeting details and format

The interaction is scheduled to begin at 10:00 am and will include both one-on-one and group meetings. The event is organized by Nuvama Emerging India CEO Forum 2026. The company stated that changes to the schedule may occur due to exigencies on the part of the host or the company.

Date	Time	Nature of meeting	Location
September 28, 2026	10:00 am onwards	1x1 / Group Meeting	Mumbai

Regulatory compliance and disclosures

This intimation is submitted pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company explicitly noted that no unpublished price sensitive information (UPSI) is intended to be discussed during these interactions.

The disclosure was signed by Dimple Ashwinbhai Mehta, Company Secretary & Compliance Officer, on September 23, 2026. Sudeep Pharma is registered in Gujarat with its corporate office located in Vadodara.

Historical Stock Returns for Sudeep Pharma

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-0.50%	+0.02%	+4.14%	+102.48%	+54.98%	+54.98%

How might Sudeep Pharma's participation in the Nuvama forum influence institutional investor sentiment and stock liquidity in the coming quarter?

What specific growth strategies or capacity expansion plans are likely to be highlighted by Sudeep Pharma management to attract emerging India-focused investors?

Could the networking opportunities at this forum lead to strategic partnerships or M&A discussions for Sudeep Pharma in the API or formulation segments?

Sudeep Pharma

View Company Insights

View All News

Sudeep Pharma cancels Gujarat plant visit scheduled for Sep 23-24

0 min read | Published on 16 Sept 2026, 11:27 AM |Updated on 22 Sept 2026, 12:50 PM

Reviewed by

Jubin VScanX News Team

Add as a preferred
source on Google

Key Highlights

Sudeep Pharma cancelled the analyst/investor plant visit scheduled for September 23-24, 2026.
The cancellation was due to exigencies, as per a regulatory filing on September 22, 2026.
The original schedule included visits in Gujarat starting at 11:00 am on both days.

*this image is generated using AI for illustrative purposes only.

Sudeep Pharma Limited has cancelled the analyst and investor plant visit previously scheduled for September 23 and 24, 2026 in Gujarat. The cancellation is attributed to exigencies on the part of the company.

The company had initially announced the meetings to begin at 11:00 am on both days. Discussions were intended to be strictly based on publicly available information, with no unpublished price-sensitive information (UPSI) slated for discussion.

Regulatory Disclosure

This cancellation was intimated pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was signed by Dimple Mehta, Company Secretary and Compliance Officer, on September 22, 2026.